Become a Member

written by reader Any ideas on “Super Aspirin” in stage 3 trials being touted by Aaron Gentzler’s Breakthrough Technology Alert Oct 2016

By caperry48, October 11, 2016

New product is supposed to be far better.
”Because in one study, this company’s leading drug worked 36 times faster than the current industry standard.
If that’s not enough, this same drug has also been shown to be more effective than the industry standard at just 1/4th of the dosage.
In other words, it takes less of this company’s drug to have a faster impact than the current standard.
With ZERO side effects.
$7. Pennsylvania Biotech

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

2 Comments
Inline Feedbacks
View all comments
jamessko
jamessko
October 14, 2016 3:58 pm

yes, Travis, it would be great if you have a quick take on this. it looks a lot like the “Delta 9” promo that you covered in december 2014,

👍 26
dsedam
Member
dsedam
October 15, 2016 7:02 pm

Any idea who this Pennsylvania Biotech company 107 from New York City.

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info  
34
0
Would love your thoughts, please comment.x
()
x